Predictors of relapse in the second follow-up year post cognitive-behavior therapy for panic disorder;Preditores de recaída no segundo ano após terapia cognitivocomportamental para pacientes com transtorno de pânico

Revista Brasileira de Psiquiatria

Volumn 33, Issue 1, 2011, Pages 23-29

  Heldt, Elizeth ^a,b   Kipper, Letícia ^b   Blaya, Carolina ^b   Salum, Giovanni A ^b   Hirakata, Vânia N ^b   Otto, Michael W ^c   Manfro, Gisele G ^a,b  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c BOSTON UNIVERSITY   (United States)

Author keywords

Cognitive therapy; Follow up studies; Panic disorder; Relapse; Stressful events

Indexed keywords

ADULT; ANXIETY; ARTICLE; CLINICAL FEATURE; COGNITIVE THERAPY; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; LIFE EVENT; MAJOR CLINICAL STUDY; MALE; PANIC; PSYCHIATRIC TREATMENT; PSYCHOSOCIAL ENVIRONMENT; RECURRENT DISEASE; STRESS; TREATMENT OUTCOME;

ADULT; COGNITIVE THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PANIC DISORDER; RECURRENCE; TIME FACTORS;

EID: 79956315384     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-44462010005000005     Document Type: Article

References (35)

1. Kessler RC, Chiu WT, Jin R, Ruscio AM, Shear K, Walters EE. The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2006;63(4):415-24.
2. Mendlowicz MV, Stein MB. Quality of life in individuals with anxiety disorders. Am J Psychiatry. 2000;157(5):669-82.
3. Katschnig H, Amering M. The long-term course of panic disorder and its predictors. J Clin Psychopharmacol. 1998;18(6 Suppl 2):6s-11s.
4. Gould RA, Otto MW, Pollack MH. A meta-analysis of treatment outcome for panic disorder. Clin Psychol Rev. 1995;15:819-44.
5. Barlow DH, Gorman JM, Shear MK, Woods SW. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial. JAMA. 2000;283(19):2529-36.
6. Biondi M, Picardi A. Increase probability of remaining in remission from panic disorder with agoraphobia after drug treatment in patients who received concurrent cognitive-behavioral therapy: a follow-up study. Psychother Psychosom. 2003;72(1):34-42.
7. Brown TA, Barlow DH. Long-term outcome in cognitive-behavior treatment of panic disorder: clinical predictors and alternative strategies for assessment. J Consult Clin Psychol. 1995;63(5):754-65.
8. Tsao JC, Mystkowski JL, Zucker BG, Craske MG. Impact of cognitive-behavioral therapy for panic disorder on comorbidity: a controlled investigation. Behav Res Ther. 2005;43(7):959-70.
9. Bruce SE, Yonkers KA, Otto MW, Eisen JL, Weisberg RB, Pagano M, Shea MT, Keller MB. Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study. Am J Psychiatry. 2005;162(6):1179-87.
10. Mennin DS, Heimberg RG. The impact of comorbid mood and personality disorders in the cognitive-behavioral treatment of panic disorder. Clin Psychol Rev. 2000;20(3):339-57.
11. Faravelli C, Pallanti S. Recent life events and panic disorder. Am J Psychiatry. 1989;146(5):622-6.
12. Manfro GG, Otto MW, Mcardle ET, Worthing JJ 3rd, Rosenbaum JF, Pollack MH. Relationship of antecedent stressful life events to childhood and family history of anxiety and the course of panic disorder. J Affect Disord. 1996;41(2):135-9.
13. Rapee RM, Litwin EM, Barlow DH. Impact of life events on subjects with panic disorder and on comparison subjects. Am J Psychiatry. 1990;147(5):640-4.
14. Roy-Byrne PP, Geraci M, Uhde TW. Life events and the onset of panic disorder. Am J Psychiatry. 1986;143(11):1424-7.
15. Watanabe A, Nakao K, Tokuyama M, Takeda M. Prediction first episode of panic attack among white-collar workers. Psychiatry Clin Neurosci. 2005;59(2):119-26.
16. Lteif NG, Mavissakalian MR. Life events and panic disorder/agoraphobia. Compr Psychiatry. 1995;36(2):118-22.
17. Wade SL, Monroe SM, Michelson LK. Chronic life stress and treatment outcome in agoraphobia with panic attacks. Am J Psychiatry. 1993;150(10):1491-5.
18. Mavissakalian MR, Guo S. Early detection of relapse in panic disorder. Acta Psychiatr Scand. 2004;110(5):393-9.
19. McNally RJ. Anxiety sensitivity and panic disorder. Biol Psychiatry. 2002;52(10):938-46.
20. Heldt E, Manfro GG, Kipper L, Blaya C, Maltz S, Isolan L, Hirakata VN, Otto MW. Treating medication-resistant panic disorder: predictors and outcome of cognitive-behavior therapy in a Brazilian public hospital. Psychother Psychosom. 2003;72(1):43-8.
21. Heldt E, Gus Manfro G, Kipper L, Blaya C, Isolan L, Otto MW. One-year follow-up of pharmacotherapy-resistant patients with panic disorder treated with cognitive-behavior therapy: outcomes and predictors of remission. Behav Res Ther. 2006;44(5):657-65.
22. Pollack MH, Otto MW, Kaspi SP, Hammerness PG, Rosenbaum JF. Cognitivebehavior therapy for treatment-refractory panic disorder. J Clin Psychiatry. 1994;55(5):200-5.
23. Amorim P. Mini International Neuropsychiatric Interview (MINI): validation of a short structured diagnostic psychiatric interview. Rev Bras Psiquiatr. 2000;22(3):106-15.
24. Sheehan DV, Lecrubier Y, Harnett SK, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC. The Mini International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22-33.
25. Guy W. Clinical Global Impressions CGI. In: ECDEU Assessment Manual for Psychopharmacology. Review Edition. Rockville, MD: National Institute of Mental Health; 1976. p.217-22.
26. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32(1):50-5.
27. Keller MB, Yonkers KA, Warshaw MG, Pratt LA, Gollan BA, Massion AO, White K, Swartz AR, Reich J, Lavori PW. Remission and relapse in subjects with panic disorder and panic with agoraphobia: a prospective short-interval naturalistic follow-up. J Nerv Ment Dis. 1994;182(5):290-6.
28. Otto MW, Jones JC, Craske MG, Barlow DH. Stopping anxiety medication: panic control therapy for benzodiazepine discontinuation (therapist guide). Oxford: Oxford University Press; 1996.
29. Dow MG, Kenardy JA, Johnson DW, Newman MG, Taylor CB, Thompson A. Prognostic indices with brief and standard CBT for panic disorder: I. Predictors of outcome. Psychol Med. 2007;37(10):1493-502.
30. McHugh RK, Otto MW, Barlow DH, Gorman JM, Shear MK, Woods SW. Cost-efficacy of individual and combined treatments for panic disorder. J Consult Clin Psychol. 2007;68(7):1038-44.
31. Otto MW, Pollack MH, Maki KM. Empirically-supported treatment for panic disorder: costs, benefits, and stepped care. J Consult Clin Psychol. 2000;68(4):556-63.
32. Otto MW, Hong JJ, Safren SA. Benzodiazepine discontinuation difficulties in panic disorder: conceptual model and outcome for cognitive-behavior therapy. Curr Pharm Des. 2002;8(1):75-80.
33. Schmidt NB, Wollaway-Bickel K, Trakowski JH, Santiago HT, Vasey M. Antidepressant discontinuation in the context of cognitive behavioral treatment for panic disorder. Behav Res Ther. 2002;40(1):67-73.
34. Whittal ML, Otto MW, Hong JJ. Cognitive-behavior therapy for discontinuation of SSRI treatment of panic disorder: a case series. Behav Res Ther. 2001;39(8):939-45.
35. Manfro GG, Heldt E, Cordioli AV, Otto MW. Cognitive-behavioral therapy in panic disorder. Rev Bras Psiquiatr. 2008;30(Suppl 2):S81-7.